Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humansK Mross, P Maessen, W J van der Vijgh, et al.Journal of the National Cancer Institute|November 6, 1991
Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancerK Hoekman, J Wagstaff, C J van Groeningen, et al.Nederlands Tijdschrift Voor Geneeskunde|March 9, 1991
[The hematopoietic growth factor GM-CSF in chemotherapy for advanced breast carcinoma]K Hoekman, J Wagstaff, E Boven, et al.Hybridoma|August 1, 1995
A monoclonal antibody against human beta-glucuronidase for application in antibody-directed enzyme prodrug therapyH J Haisma, M Van Muijen, G Scheffer, et al.Urology|April 1, 1997
Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladderC L Berendsen, W H Peters, P G Scheffer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamoleW J Jansen, H M Pinedo, C M Kuiper, et al.European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenograftsW J Jansen, H M Pinedo, C L van der Wilt, et al.Biochemical Pharmacology|October 7, 1994
Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumoursV W Ruiz van Haperen, G Veerman, E Boven, et al.British Journal of Cancer|February 24, 1998
CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated proteinW J Jansen, T M Hulscher, J van Ark-Otte, et al.Gynecologic Oncology|February 24, 2000
Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification systemG M Kolfschoten, H M Pinedo, P G Scheffer, et al.Pageof 13